Effects of omega-3 fatty acids on cognitive performance: a meta-analysis

@article{Mazereeuw2012EffectsOO,
  title={Effects of omega-3 fatty acids on cognitive performance: a meta-analysis},
  author={Graham Mazereeuw and Krista L. Lanct{\^o}t and Sarah A. Chau and Walter Swardfager and Nathan Herrmann},
  journal={Neurobiology of Aging},
  year={2012},
  volume={33},
  pages={1482.e17-1482.e29}
}
BACKGROUND Higher intake of omega-3 fatty acids (n-3 FAs) is associated with a reduced risk of Alzheimer's disease (AD) and milder forms of cognitive impairment (e.g. cognitive impairment no dementia [CIND]); however, findings from interventional trials are inconsistent. This meta-analysis examined the neuropsychological benefit of n-3 FAs in randomized double-blind placebo-controlled studies (RCTs) including healthy, CIND, or AD subjects. METHODS Literature was searched using Medline, Embase… Expand
Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
TLDR
The effects of omega-3 fatty acids supplementation in mild AD corroborate epidemiological observational studies showing that omega- 3 fatty acids may be beneficial in disease onset, when there is slight impairment of brain function. Expand
[Does Omega-3 supplementation after the age of 65 influence cognitive function? Results of a systematic review].
TLDR
Few studies to support or refute the evidence that w3-PUFA supplementation in patients aged 65 or older improves cognitive performance or prevents dementia are found. Expand
Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis
TLDR
There is no consistent evidence to support the effectiveness of omega-3 supplementation in improving cognitive function in AD patients in the short and medium term. Expand
Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis
TLDR
There is marginal evidence that n-3 PUFA supplementation effects cognition in those who are n- 3 PUFA deficient, however, there is no evidence of an effect in the general population or those with neurodevelopmental disorders. Expand
Omega-3 and its domain-specific effects on cognitive test performance in youths: A meta-analysis
TLDR
This first analysis revealed no main effect of omega-3 fatty acid supplementation on domain-specific cognitive test performance in youths, and beneficial effects of EPA and DHA formulations in the domains of long-term memory, working memory and problem solving were identified. Expand
Omega-3 fatty acids and cognitive decline: a systematic review.
TLDR
A Systematic Review concludes that omega-3 supplementation might have a positive effect on cognitive function and could be used as a preventive or therapeutic tool for cognitive decline in aged or elder adults. Expand
Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis.
TLDR
The existing literature suggests that LCn-3PUFA supplementation could provide a mild benefit in improving memory function in non-demented older adults. Expand
Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.
As the process of Alzheimer's disease (AD) begins years before disease onset, searching for prevention strategies is of major medical and economic importance. Nutritional supplementation withExpand
Cognitive changes with omega-3 polyunsaturated fatty acids in non-demented older adults with low omega-3 index
TLDR
There is some evidence that n-3 PUFAs might be beneficial for the maintenance of executive functioning in older adults at risk of dementia with low omega-3 index, but this exploratory finding requires further confirmation. Expand
Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
TLDR
Fishery products are recommended as dietary sources and are associated with lower risk of cognitive impairment and marine-derived DHA was associated withLower risk of dementia and AD but without a linear dose-response relation. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 76 REFERENCES
A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease
TLDR
The combination of ω-3+LA slowed cognitive and functional decline in AD over 12 months and the combination of omega-3 fatty acids plus alpha-lipoic acid as a potential treatment in AD is warranted. Expand
Omega 3 fatty acid for the prevention of dementia.
TLDR
There is no good evidence to support the use of dietary or supplemental omega 3 PUFA for the prevention of cognitive impairment or dementia, and there are no randomized trials found in the search that met the selection criteria. Expand
Effect of fish oil on cognitive performance in older subjects
TLDR
In this randomized, double-blind, placebo-controlled trial, there were no significant differential changes in any of the cognitive domains for either low-dose or high-dose fish oil supplementation compared with placebo. Expand
Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial
TLDR
Increased intakes of DHA and EPA benefited mental health in older people with MCI and improved self-reported physical health was associated with increased DHA, and increasing n-3 PUFA intakes may reduce depressive symptoms and the risk of progressing to dementia. Expand
The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study
TLDR
It suggests that omega-3 PUFAs were well tolerable in this population and further studies should be considered with a larger-sample size, diet registration, higher dosages, comparisons between different combinations ofPUFAs, and greater homogeneity of participants, especially those with mild Alzheimer's disease and mild cognitive impairment. Expand
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
TLDR
Administration of omega-3 fatty acid in patients with mild to moderate AD did not delay the rate of cognitive decline according to the MMSE or the cognitive portion of the Alzheimer Disease Assessment Scale, and positive effects were observed in a small group of patients with very mild AD. Expand
Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging.
TLDR
Higher intake of PUFA and MUFA was associated with a reduced likelihood of MCI among elderly persons in the population-based setting. Expand
Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.
TLDR
In this Dutch cohort, who had a moderate consumption of fish and omega-3 PUFAs, these dietary factors do not appear to be associated with long-term dementia risk. Expand
Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease
TLDR
Clinical trials investigating the effects of omega-3 fatty acid supplementation in AD failed to demonstrate its efficacy in the treatment of AD, but produced intriguing data suggesting that the beneficial effects may depend on the stage of disease, other dietary mediators, and apolipoprotein E status. Expand
Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature.
  • Tina Huang
  • Medicine
  • Journal of Alzheimer's disease : JAD
  • 2010
TLDR
This review provides background and context needed for interpretation of the findings, summaries of the literature grouped by longitudinal studies of fish, dietary n-3 FAs, blood levels of fatty acids, postmortem studies, and clinical trials, and subsequent interpretation of findings. Expand
...
1
2
3
4
5
...